Figure 1
![Figure 1. Pim kinases in cancer. (A) Pim kinase pathways (adapted from Chen et al26). (B) Chemical structure of imidazo[1,2-b]pyridazine compound SGI-1776.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/118/3/10.1182_blood-2010-12-323022/4/zh89991174840001.jpeg?Expires=1735526766&Signature=bEzGF2AGk3IsVD2ALEe4UAMT3ZrkjBcjC9UfVYenwXKiPb4KXFOsj63V30DAPahawt-iRbZV1u3lU-pOTpVXDXNOnT0IDRNIhHqTylKsWo6GzMxALnjamoUJS0Klh~ed4fsZZF7sP1Eqb9UdMz1yZ8JWwW3C8PcLsIrels6gfjEXZi9sC8ywK7tYGzG5K~~K8ftKezhpf3mgZOezgJJutppR8dMnIDdc7fwz~Wyj7wUr71Rt7AUhhKTnbuxL-wBCOC3yXtKQIlTxV0Px9CdRcvondy4wTO2tWNkK1sxxjxprp6BLl7sBrmiElEGpHaiYuEO3Q093J0l4YL4pOy80kQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Pim kinases in cancer. (A) Pim kinase pathways (adapted from Chen et al26). (B) Chemical structure of imidazo[1,2-b]pyridazine compound SGI-1776.
Pim kinases in cancer. (A) Pim kinase pathways (adapted from Chen et al26). (B) Chemical structure of imidazo[1,2-b]pyridazine compound SGI-1776.
